Ying Cheng

机构：Zhengzhou University, Zhengzhou University of Science and Technology, Jilin Province Tumor Hospital · ORCID：0000-0002-1517-501X

发表论文 26 篇 · 总被引 780 次 · h-index 6

代表论文

Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer (2018 · JAMA Oncology · 被引 629)
The impact of previous therapy strategy on the efficiency of anlotinib hydrochloride as a third-line treatment on patients with advanced non-small cell lung cancer (NSCLC): a subgroup analysis of ALTER0303 trial (2019 · Translational Lung Cancer Research · 被引 37)
Effect of anlotinib as a third‐ or further‐line therapy in advanced non‐small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial (2020 · Cancer Medicine · 被引 33)
Anlotinib for patients with small cell lung cancer and baseline liver metastases: A post hoc analysis of the ALTER 1202 trial (2021 · Cancer Medicine · 被引 21)
P2.12-26 The Impact of Anlotinib for Relapsed SCLC Patients with Brain Metastases: A Subgroup Analysis of ALTER 1202 (2019 · Journal of Thoracic Oncology · 被引 11)
Precise identification of somatic and germline variants in the absence of matched normal samples (2024 · Briefings in Bioinformatics · 被引 8)